Company: VCYT
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001384101-25-000110
Chunk: 47

Company: VERACYTE, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 47
---
751 21%7,887 6,556 1,331 20%Total revenue130,164 114,428 15,736 14%244,637 211,272 33,365 16%Cost of revenue:    Cost of testing revenue32,407 27,920 4,487 16%60,667 53,899 6,768 13%Cost of product revenue1,749 1,874 (125)(7)%3,171 4,518 (1,347)(30)%Cost of biopharmaceutical and other revenue3,572 3,812 (240)(6)%6,270 6,650 (380)(6)%Intangible asset amortization - cost of revenue2,667 2,909 (242)(8)%5,252 5,824 (572)(10)%Total cost of revenue40,395 36,515 3,880 11%75,360 70,891 4,469 6%Gross profit89,769 77,913 11,856 15%169,277 140,381 28,896 21%Operating expenses:Research and development16,264 16,465 (201)(1)%33,984 32,430 1,554 5%Selling and marketing25,316 24,216 1,100 5%49,770 47,998 1,772 4%General and administrative32,331 31,745 586 2%66,139 57,955 8,184 14%Impairment of assets20,505 — 20,505 NM20,505 429 20,076 4680%Intangible asset amortization - operating expenses621 881 (260)(30)%1,243 1,619 (376)(23)%Total operating expenses95,037 73,307 21,730 30%171,641 140,431 31,210 22%Income (loss) from operations(5,268)4,606 (9,874)(214)%(2,364)(50)(2,314)4628%Other income, net6,518 2,755 3,763 137%11,042 5,503 5,539 101%Income (loss) before income taxes1,250